​
​

Viracta Therapeutics Ownership | Who Owns Viracta Therapeutics?

OverviewForecastRevenueFinancialsChart

Viracta Therapeutics Ownership Summary

Viracta Therapeutics is owned by 22.95% institutional investors, 2.84% insiders, and 74.21% retail investors. Vanguard group is the largest institutional shareholder, holding 2.95% of VIRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.30% of its assets in Viracta Therapeutics shares.

VIRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockViracta Therapeutics22.95%2.84%74.21%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.16M2.95%$631.39K
Samsara biocapital689.71K1.75%$375.00K
Laurion capital management lp407.30K1.04%$221.45K
Aisling capital management lp288.57K0.73%$156.90K
Blackrock273.30K0.69%$148.59K
Geode capital management270.77K0.69%$147.26K
Renaissance217.70K0.55%$118.36K
Morgan stanley134.54K0.34%$73.15K
Bridgeway capital management74.00K0.19%$40.23K
State street65.87K0.17%$35.81K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Samsara biocapital689.71K0.08%$375.00K
Aisling capital management lp288.57K0.07%$156.90K
Planning capital management7.27K0.00%$3.95K
Laurion capital management lp407.30K0.00%$221.45K
Wealthtrust axiom11.40K0.00%$6.20K
Inspirion wealth advisors15.00K0.00%$8.16K
Virtu financial30.79K0.00%$17.00K
Rp management3.70K0.00%$2.00K
Trust co of toledo na /oh/12.32K0.00%$6.70K
Xtx topco19.20K0.00%$10.44K

Top Buyers

HolderShares% AssetsChange
Virtu financial30.79K0.00%30.79K
Geode capital management270.77K-18.07K
Morgan stanley134.54K-16.53K
Renaissance217.70K0.00%15.20K
Tower research capital llc (trc)12.65K0.00%3.76K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il---3.61M
Ensign peak advisors---61.60K
Blackrock273.30K--30.68K
Mai capital management---27.42K
United bank---25.20K

Sold Out

HolderChange
Qube research-2.00
Newedge advisors-14.00
Nbc securities-1.40K
Royal bank of canada-2.07K
Beacon pointe advisors-15.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202441-9,025,612-3.92%223.88%10-23.08%833.33%
Mar 31, 202441-6.82%9,393,496-3.67%243.83%13-13.33%6-14.29%
Dec 31, 2023442.33%9,751,2650.61%253.99%15-6.25%7-12.50%
Sep 30, 2023432.38%9,692,391-2.75%253.74%1645.45%8-20.00%
Jun 30, 202342-14.29%9,966,868-18.43%252.57%1110.00%10-23.08%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv513.47K1.30%-131.32K
Vanguard Institutional Extnd Mkt Idx Tr282.49K0.72%-
Fidelity Extended Market Index145.27K0.37%-9.48K
Bridgeway Ultra-Small Company Market74.00K0.19%-
BlackRock Extended Equity Market K49.16K0.12%-21.00
Fidelity Total Market Index41.22K0.10%-
Fidelity Series Total Market Index28.47K0.07%-
Vanguard Instl Ttl Stck Mkt Idx Tr28.45K0.07%-
Fidelity Nasdaq Composite Index25.76K0.07%-
NT Ext Equity Mkt Idx Fd - NL18.41K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 27, 2024Chevallard Daniel R. CFO and COOSell$2.49K
Nov 30, 2023Rothera Mark President and CEOBuy$25.73K
Dec 01, 2023Rothera Mark President and CEOBuy$23.63K
Nov 28, 2023Chevallard Daniel R. CFO and COOSell$1.86K
Aug 28, 2023Chevallard Daniel R. CFO and COOSell$5.09K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1-1
2023 Q421
2023 Q3-1
2023 Q2-1

VIRX Ownership FAQ

Who Owns Viracta Therapeutics?

Viracta Therapeutics shareholders are primarily institutional investors at 22.95%, followed by 2.84% insiders and 74.21% retail investors. The average institutional ownership in Viracta Therapeutics's industry, Biotech Stocks , is 44.70%, which Viracta Therapeutics falls below.

Who owns the most shares of Viracta Therapeutics?

Viracta Therapeutics’s largest shareholders are Vanguard group (1.16M shares, 2.95%), Samsara biocapital (689.71K shares, 1.75%), and Laurion capital management lp (407.3K shares, 1.04%). Together, they hold 5.74% of Viracta Therapeutics’s total shares outstanding.

Does Blackrock own Viracta Therapeutics?

Yes, BlackRock owns 0.69% of Viracta Therapeutics, totaling 273.3K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 148.59K$. In the last quarter, BlackRock decreased its holdings by -30.683K shares, a -10.09% change.

Who is Viracta Therapeutics’s biggest shareholder by percentage of total assets invested?

Samsara biocapital is Viracta Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.08% of its assets in 689.71K Viracta Therapeutics shares, valued at 375K$.

Who is the top mutual fund holder of Viracta Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Viracta Therapeutics shares, with 1.30% of its total shares outstanding invested in 513.47K Viracta Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools